Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 1 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (20%) |
| Double-patenting + other | 2 (40%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOU, LIYUAN | 2 | 42.9% | +59.0% |
| JEAN-LOUIS, SAMIRA JM | 1 | 61.0% | +45.2% |
| SHTERENGARTS, SAMANTHA L | 1 | 79.5% | +8.0% |
| FETTEROLF, BRANDON J | 1 | 52.0% | +17.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18934442 | CARBAMOTHIOATE, AND CARBAMODITHIOATE DERIVATIVES OF MDMA, MDA OR ITS OPTICALLY ACTIVE (R)- OR (S)-MDMA AND MDA ISOMERS | JEAN-LOUIS, SAMIRA JM | — |
| 18744218 | PRODRUGS OF MDMA, MDA, AND DERIVATIVES THEREOF | SHTERENGARTS, SAMANTHA L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19431012 | SALT FORMS OF R-MDMA AND METHODS USING THE SAME | MOU, LIYUAN | — |
| 18934442 | CARBAMOTHIOATE, AND CARBAMODITHIOATE DERIVATIVES OF MDMA, MDA OR ITS OPTICALLY ACTIVE (R)- OR (S)-MDMA AND MDA ISOMERS | JEAN-LOUIS, SAMIRA JM | — |
| 18737447 | SUBSTITUTED BENZOFURAN PROPYL AMINE MODULATORS OF MONOAMINERGIC TRANSPORTERS | FETTEROLF, BRANDON J | — |
| 18401401 | SALT FORMS OF R-MDMA AND METHODS USING THE SAME | MOU, LIYUAN | — |
| Art Unit | Apps |
|---|---|
| 1628 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19431012 | SALT FORMS OF R-MDMA AND METHODS USING THE SAME | MOU, LIYUAN | 1628 | §103§112DP | Final Rejection | — | Pending | Dec 23, 2025 |
| 18934442 | CARBAMOTHIOATE, AND CARBAMODITHIOATE DERIVATIVES OF MDMA, MDA OR ITS OPTICALLY ACTIVE (R)- OR (S)-MDMA AND MDA ISOMERS | JEAN-LOUIS, SAMIRA JM | — | §102§112 | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18744218 | PRODRUGS OF MDMA, MDA, AND DERIVATIVES THEREOF | SHTERENGARTS, SAMANTHA L | — | §102§112 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18737447 | SUBSTITUTED BENZOFURAN PROPYL AMINE MODULATORS OF MONOAMINERGIC TRANSPORTERS | FETTEROLF, BRANDON J | — | §102 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18401401 | SALT FORMS OF R-MDMA AND METHODS USING THE SAME | MOU, LIYUAN | 1628 | §102§103§112DP | Non-Final OA | — | Pending | Dec 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial